# Vivos Inc. (RDGL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RDGL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 70.0K | $ -3.14M | $ -2.21M | $ 114.3K | $ 1.66M |
| 2024 | $ 29.4K | $ -3.06M | $ -1.77M | $ 0 | $ 2.15M |
| 2023 | $ 29.2K | $ -3.13M | $ -1.40M | $ 0 | $ 1.37M |
| 2022 | $ 40.8K | $ -2.76M | $ -1.25M | $ 0 | $ 1.66M |
| 2021 | $ 35.4K | $ -3.00M | $ -1.15M | $ 0 | $ 1.47M |
| 2020 | $ 3.8K | $ -1.22M | $ -1.12M | $ 344.4K | $ 32.0K |
| 2019 | $ 12.3K | $ -2.08M | $ -1.08M | $ 786.4K | $ -1.48M |
| 2018 | $ 0 | $ -10.17M | $ -925.1K | $ 53.8K | $ -942.2K |
| 2017 | $ 5.5K | $ -8.65M | $ -1.74M | $ 2.95M | $ -4.26M |
| 2016 | $ 640.4K | $ -13.56M | $ -2.65M | $ 876.7K | $ -17.16M |
| 2015 | $ 1.3K | $ 8.75M | $ -1.68M | $ 3.07M | $ -14.33M |
| 2014 | $ 2.3K | $ -25.59M | $ -1.61M | $ 5.07M | $ -20.16M |
| 2013 | $ 298.2K | $ -4.94M | $ -2.91M | $ 1.03M | $ -8.97M |
| 2012 | $ 358.0K | $ -12.40M | $ -2.73M | $ 1.06M | $ -9.85M |
| 2011 | $ 578.3K | $ -4.04M | $ -1.26M | $ 3.59M | $ -4.84M |
| 2010 | $ 546.0K | $ -6.14M | $ -1.19M | $ 3.57M | $ -2.96M |
| 2009 | $ 485.1K | $ -6.04M | $ -2.01M | $ 3.58M | $ -1.81M |
| 2008 | $ 406.2K | $ -10.07M | $ -4.93M | $ 2.59M | $ -3.70M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.07 |
| Liabilities / Eq | 0.12 |
| Current Ratio | 14.00 |

## Other views

- [Metrics](https://sponda.capital/en/RDGL.md)
- [Charts](https://sponda.capital/en/RDGL/charts.md)
- [Compare](https://sponda.capital/en/RDGL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.